BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Vectura Group plc 

1 Prospect West

Chippenham  Wiltshire  SN14 6FH  United Kingdom
Phone: 44-0-1249-667700 Fax: 44-0-1249-667701


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical






 Company News
Vectura Group plc (VEC.L)’s Investigational Drug/Device Combination VR475 Met Primary Endpoint And Has Shown Significant Clinical Benefit In A Phase 2b/3 Trial In Severe Asthma Patients 12/11/2014 6:35:04 AM
Vectura Group plc (VEC.L) Release: Approval In Ireland And Czech Republic For Innovative Respiratory Inhaler AirFluSal Forspiro 11/19/2014 9:31:33 AM
Vectura Group plc (VEC.L) Appoints Andrew Oakley As Group CFO 11/18/2014 4:17:10 PM
Vectura Group plc (VEC.L) VR315 U.S. Development Milestone 11/7/2014 9:10:52 AM
Vectura Group plc (VEC.L) Approval In Baltics For Innovative Respiratory Inhaler AirFluSal® Forspiro® 11/4/2014 10:10:20 AM
Vectura Group plc (VEC.L) Release: Approval In Portugal For Innovative Respiratory Inhaler AirFluSal® Forspiro® 10/9/2014 8:08:57 AM
Vectura Group plc (VEC.L) Release: Presentation At ERS 9/5/2014 9:03:54 AM
Vectura Group plc (VEC.L) Release: Announcement Of Commercial Arrangement With Pfizer Inc. (PFE) UK To Promote Ultibro® Breezhaler® And Seebri® Breezhaler® In The United Kingdom 9/4/2014 2:32:02 PM
Vectura Group plc (VEC.L) Release: Presentations At ERS 9/2/2014 9:47:24 AM
Vectura Group plc (VEC.L) First Approval In Latin America For Innovative Respiratory Inhaler AirFluSal#0174; Forspiro#0174; 8/21/2014 9:31:49 AM
12345678910